Results 211 to 220 of about 17,815 (221)

Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab “infusion group”

Multiple Sclerosis Journal, 2013
T Kumpfel, M Krumbholz, Bernhard Hemmer   +2 more
exaly  

Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA’s adverse event reporting system

Expert Opinion on Drug Safety, 2016
Dennis W Raisch, Cheng Chen, Charles L Bennett   +2 more
exaly  

Characterization of the VP1 loop mutations widespread among JC polyomavirus isolates associated with progressive multifocal leukoencephalopathy

Biochemical and Biophysical Research Communications, 2005
Huai-Ying Zheng, Hiroshi Ikegaya, Tomokazu Takasaka   +2 more
exaly  

Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy

Multiple Sclerosis Journal, 2015
Theo Rispens, Bob W Van Oosten, M P Wattjes   +2 more
exaly  

A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JCV testing

International Journal of Neuroscience, 2013
Jared R Brosch, Aaron P Kamer, David H Mattson   +2 more
exaly  

Progressive Multifocal Leukoencephalopathy Complicating Waldenström's Macroglobulinaemia

Leukemia and Lymphoma, 2003
Mónica A Slavin, John F Seymour
exaly  

Progressive Multifocal Leukoencephalopathy

1977
Richard T. Johnson, Opendra Narayan, Leslie P. Weiner, John E. Greenlee   +3 more
openaire   +1 more source

PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY.

New York state journal of medicine, 1996
S, DELAPAVA, J W, PICKREN
openaire   +1 more source

Progressive multifocal leukoencephalopathy

2005
openaire   +1 more source

Progressive Multifocal Leukoencephalopathy

2009
openaire   +1 more source